MBX Biosciences, Inc. (MBX)
66.76
-1.86
(-2.71%)
USD |
NASDAQ |
Aug 26, 16:00
66.50
-0.26
(-0.39%)
After-Hours: 05:46
MBX Biosciences Market Cap : 3.201B for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 3.201B |
| August 25, 2026 | 3.290B |
| August 24, 2026 | 3.183B |
| August 21, 2026 | 3.181B |
| August 20, 2026 | 3.181B |
| August 19, 2026 | 3.280B |
| August 18, 2026 | 3.190B |
| August 17, 2026 | 3.273B |
| August 14, 2026 | 3.288B |
| August 13, 2026 | 3.216B |
| August 12, 2026 | 3.211B |
| August 11, 2026 | 3.165B |
| August 10, 2026 | 3.172B |
| August 07, 2026 | 3.252B |
| August 06, 2026 | 3.218B |
| August 05, 2026 | 3.236B |
| August 04, 2026 | 3.390B |
| August 03, 2026 | 3.064B |
| July 31, 2026 | 3.136B |
| July 30, 2026 | 3.162B |
| July 29, 2026 | 3.043B |
| July 28, 2026 | 2.857B |
| July 27, 2026 | 2.916B |
| July 24, 2026 | 2.949B |
| July 23, 2026 | 3.024B |
| Date | Value |
|---|---|
| July 22, 2026 | 2.773B |
| July 21, 2026 | 2.868B |
| July 20, 2026 | 2.861B |
| July 17, 2026 | 2.993B |
| July 16, 2026 | 2.774B |
| July 15, 2026 | 2.886B |
| July 14, 2026 | 2.692B |
| July 13, 2026 | 2.856B |
| July 10, 2026 | 2.904B |
| July 09, 2026 | 3.126B |
| July 08, 2026 | 2.937B |
| July 07, 2026 | 2.949B |
| July 06, 2026 | 2.745B |
| July 02, 2026 | 2.750B |
| July 01, 2026 | 2.660B |
| June 30, 2026 | 2.626B |
| June 29, 2026 | 2.562B |
| June 26, 2026 | 2.488B |
| June 25, 2026 | 2.396B |
| June 24, 2026 | 2.302B |
| June 23, 2026 | 2.207B |
| June 22, 2026 | 2.089B |
| June 18, 2026 | 2.047B |
| June 17, 2026 | 1.978B |
| June 16, 2026 | 1.907B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amylyx Pharmaceuticals, Inc. | 4.130B |
| ANI Pharmaceuticals, Inc. | 1.713B |
| Corcept Therapeutics, Inc. | 12.93B |
| Veru, Inc. | 47.74M |
| Johnson & Johnson | 650.22B |
Market Cap Related Metrics
| PEG Ratio | -6.313 |
| Price to Book Value | 7.816 |
| Price | 66.76 |
| Earnings Yield | -3.60% |
| PEGY Ratio | -6.313 |